Today's guest is Brandon Allgood, Chief Data Officer at FogPharma. Founded in 2016, FogPharma is a clinical-stage company pioneering a new class of drugs to address the limitations of today’s precision medicines and achieve universal druggability. FogPharma’s discovery engine integrates cutting-edge technologies that dramatically accelerate the speed and scalability of drug discovery to advance novel Helicon therapeutics against important, previously intractable targets across virtually all disease areas.

With 23 years of experience in developing AI based platforms in healthcare, Brandon is a serial entrepreneur focused on applying machine learning and large scale computational methods to improve human health. Brandon previously helped build three companies, Valo Health, Numerate and Pharmix, at the forefront of applying modern ML and computational methods to drug discovery and development in diverse subfields, including chemistry, biology, clinical trials and real-world health data. 

In this episode, Brandon talks about:

His journey from cosmology to drug discovery at FogPharma,

An overview of Fog Pharma's focus on peptides,

How AI optimizes drug design, biology understanding & patient response prediction,

Taking a data-driven approach to their drug discovery platform